Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of dasatinib with
bortezomib in the treatment of relapsed or refractory multiple myeloma.